Innate Pharma (IPHA) News Today

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

$2.44

+0.09 (+3.83%)

(As of 04/19/2024 ET)

Source

Source	Headline
	Short Interest in Innate Pharma S.A. (NASDAQ:IPHA) Decreases By 13.7% americanbankingnews.com - April 16 at 5:00 AM
	Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients businesswire.com - April 15 at 1:00 AM
	Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024 businesswire.com - April 15 at 1:00 AM
	Innate Pharma (NASDAQ:IPHA) Stock Rating Reaffirmed by HC Wainwright americanbankingnews.com - April 13 at 5:32 AM
	Innate Pharma's (IPHA) "Buy" Rating Reaffirmed at HC Wainwright marketbeat.com - April 11 at 8:25 AM
	Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate businesswire.com - April 10 at 1:00 AM
	Innate Pharma Announces Its Participation in Upcoming Investor Conference finance.yahoo.com - April 9 at 1:08 AM
	Innate Pharma Announces Its Participation in Upcoming Investor Conference businesswire.com - April 9 at 1:00 AM
	Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F finance.yahoo.com - April 5 at 4:24 AM
	Innate Pharma Files Its 2023 Universal Registration Document (Document d'enregistrement Universel) and 2023 Annual Report on Form 20-F businesswire.com - April 5 at 3:34 AM
	Innate Pharma S.A. (NASDAQ:IPHA) Short Interest Up 13.6% in March marketbeat.com - April 2 at 7:37 AM
	Innate Pharma S.A. (IPHA) Q4 2023 Earnings Call Transcript seekingalpha.com - March 23 at 5:13 PM
	Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript finance.yahoo.com - March 22 at 12:04 PM
	Innate Pharma (NASDAQ:IPHA) Earns Buy Rating from HC Wainwright marketbeat.com - March 22 at 8:17 AM
	Innate Pharma SA: Innate Pharma Reports Full Year 2023 Financial Results and Business Update finanznachrichten.de - March 21 at 7:21 AM
	Innate Pharma Reports Full Year 2023 Financial Results and Business Update businesswire.com - March 21 at 2:00 AM
	Innate Pharma SA: Innate Pharma Announces Its Participation to Upcoming Investor Conference finanznachrichten.de - March 19 at 2:19 AM
	Innate Pharma Announces Its Participation to Upcoming Investor Conference businesswire.com - March 19 at 2:00 AM
	Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results businesswire.com - March 14 at 2:00 AM
	Innate Pharma SA: Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024 finanznachrichten.de - March 6 at 5:04 PM
	Innate Pharma SA: Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin's Lymphoma finanznachrichten.de - March 6 at 5:04 PM
	Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma finance.yahoo.com - March 6 at 5:04 PM
	Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin's Lymphoma businesswire.com - March 6 at 1:00 AM
	Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024 businesswire.com - March 6 at 1:00 AM
	Innate Pharma Announces Its Participation to Upcoming Investor Conference businesswire.com - February 21 at 1:00 AM
	Innate Pharma (NASDAQ:IPHA) Trading Up 0.4% marketbeat.com - January 30 at 1:35 AM
	Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024 finance.yahoo.com - January 12 at 1:59 AM
	Innate Pharma SA: Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program finanznachrichten.de - January 4 at 2:17 AM
	Innate Pharma SA: Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board finanznachrichten.de - January 4 at 2:17 AM
	Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board finance.yahoo.com - January 4 at 2:17 AM
	Innate Pharma S.A. (NASDAQ:IPHA) Short Interest Update marketbeat.com - January 3 at 8:44 AM
	IPHYF Innate Pharma S.A. seekingalpha.com - December 31 at 3:21 PM
	Innate Pharma SA ADR morningstar.com - December 19 at 8:31 PM
	Innate Pharma CEO Mahjoubi to leave company msn.com - December 18 at 12:41 PM
	Innate Pharma Stock (NASDAQ:IPHA), Analyst Ratings, Price Targets, Predictions benzinga.com - December 1 at 10:00 AM
	Innate Pharma Stock (NASDAQ:IPHA) Dividends: History, Yield and Dates benzinga.com - December 1 at 10:00 AM
	Promising Clinical Outcomes and Strategic Partnerships Reinforce Buy Rating for Innate Pharma markets.businessinsider.com - November 17 at 3:31 AM
	Promising Updates on Lacutamab and ANKET Portfolio Fuel Buy Rating for Innate Pharma’s Stock markets.businessinsider.com - November 16 at 8:50 PM
	Innate Pharma S.A. (NASDAQ:IPHA) Q3 2023 Earnings Call Transcript finance.yahoo.com - November 15 at 1:20 PM
	Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update finance.yahoo.com - November 14 at 2:27 AM
	Number of Shares and Voting Rights of Innate Pharma as of October 3, 2023 finance.yahoo.com - October 9 at 8:43 AM
	Innate Pharma Announces Encore Presentation of Interim Results of Phase 2 TELLOMAK Study With Lacutamab With Updated Olsen 2022 Criteria at the EORTC Cutaneous Lymphoma Tumour ... businesswire.com - October 7 at 1:55 PM
	Innate Pharma Provides Update on Lacutamab Clinical Program finance.yahoo.com - October 5 at 1:46 AM
	Innate Pharma S.A. (NASDAQ:IPHA) Short Interest Down 8.1% in August marketbeat.com - September 19 at 7:21 AM
	Innate Pharma Reports First Half 2023 Financial Results and Business Update finance.yahoo.com - September 14 at 2:14 AM
	Innate Pharma Announces Its Participation to Upcoming Investor Conferences and Conference Call for First Half 2023 Business Update finance.yahoo.com - August 29 at 2:06 AM
	Innate Pharma S.A. (IPHA) finance.yahoo.com - August 9 at 3:28 PM
	H.C. Wainwright Keeps Their Buy Rating on Innate Pharma (IPHA) markets.businessinsider.com - June 16 at 7:26 AM
	Innate Pharma Highlights Increased Lacutamab Clinical Activity From Interim Results of Phase 2 TELLOMAK Study With Updated Olsen Criteria finance.yahoo.com - June 16 at 2:25 AM
	Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides at the International Conference on Malignant Lymphoma finance.yahoo.com - June 12 at 12:59 PM

Get Innate Pharma News Delivered to You Automatically

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

IPHA Media Mentions By Week

IPHA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IPHA
News Sentiment
▼
0.48

0.52
▲
Average
Medical
News Sentiment

IPHA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IPHA Articles
This Week
▼
4

1
▲
IPHA Articles
Average Week

Get Innate Pharma News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:IPHA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Innate Pharma (IPHA) News Today

IPHA Media Mentions By Week

IPHA Media Sentiment

IPHA News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info